BJOG : an international journal of obstetrics and gynaecology
-
Randomized Controlled Trial Multicenter Study
Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial.
To assess the cost-effectiveness of using magnesium sulphate for pre-eclampsia to prevent eclampsia. ⋯ Magnesium sulphate for pre-eclampsia costs less and prevents more eclampsia in low GNI than in high GNI countries. Cost-effectiveness substantially improves if it is used only for severe pre-eclampsia, or the purchase price is reduced in low GNI countries.